, Core A The Stanford Alzheimer's Disease Research Center (ADRC) will serve as a shared resource to facilitate and enhance multidisciplinary and interdisciplinary research in Alzheimer's disease and related disorders; our mission is to specialize in the collection, analysis and dissemination of data sets that is relevant to both Alzheimer's disease and Parkinson's disease research. The Administrative Core (Core A) serves as an administrative structure to direct, facilitate and support the goals of the Stanford ADRC. It assures compliance with NIH policy requirements and provides a forum for planning. It will accomplish its goals through the following specific aims: (1) Coordinate activities of the ADRC Cores, committees, and research projects; (2) Establish advisory committees, which will support Center aims through recommendations, guidance, and critiques; (3) Oversee, monitor, and ensure compliance with reporting procedures, policies, and guidelines of the NIH, institutional review board, university, and other relevant bodies; (4) Stimulate innovative research in Alzheimer's disease and related disorders by existing and new investigators; and (5) Promote research and educational collaborations with other Alzheimer's Disease Centers, universities, health professionals, Alzheimer and Parkinson caregivers, and the wider community.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG047366-04
Application #
9483582
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
4
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Turk, Katherine W; Flanagan, Margaret E; Josephson, Samuel et al. (2018) Psychosis in Spinocerebellar Ataxias: a Case Series and Study of Tyrosine Hydroxylase in Substantia Nigra. Cerebellum 17:143-151
Bharadwaj, Rajnish; Cimino, Patrick J; Flanagan, Margaret E et al. (2018) Application of the condensed protocol for the NIA-AA guidelines for the neuropathological assessment of Alzheimer's disease in an academic clinical practice. Histopathology 72:433-440
Bennett, F Chris; Bennett, Mariko L; Yaqoob, Fazeela et al. (2018) A Combination of Ontogeny and CNS Environment Establishes Microglial Identity. Neuron 98:1170-1183.e8
Flanagan, Margaret E; Cholerton, Brenna; Latimer, Caitlin S et al. (2018) TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study. J Alzheimers Dis 66:1549-1558
Hohman, Timothy J; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol 75:989-998
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Askari, Nusha; Bilbrey, Ann Choryan; Garcia Ruiz, Iliana et al. (2018) Dementia Awareness Campaign in the Latino Community: A Novel Community Engagement Pilot Training Program with Promotoras. Clin Gerontol 41:200-208
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679

Showing the most recent 10 out of 117 publications